Another company involved in using AI to repurpose failed drugs – as well as drugs that have already been approved – is ...

Scientists have developed a coffee machine-sized 3D bioprinter that produces human-like tissue in a move they hope could ...

Novo Nordisk shares rose Monday as the company said it would present new data on the ability of semaglutide, the active ingredient in its weight-loss drugs Ozempic and Wegovy, to lower heart risks.

While PD-1/PD-L1 blockade has demonstrated remarkable clinical successes, recent studies suggest that its novel target has a ...

Pheiron and Ribo are excited to announce that the first two strategic collaboration milestones have been successfully ...

Roche has acquired rights to an obesity therapy by Denmark's Zealand Pharma in a collaboration deal worth up to $5.3 billion, ...

Variations in regulatory requirements across regions often create inefficiencies in drug development—for example, differences in manufacturing standards and stability testing protocols can lead ...

Ionis and Ultragenyx are competing to develop oligonucleotide treatments for Angelman syndrome, but will Neuren’s peptide ...

The coffee-machine-sized printer produces 3D humanlike tissue that should allow for better testing and development of ...

Orphan Drug Designation follows positive Phase 1 data presented at the 12th International Workshop on Waldenström ...

Generative AI offers the promise of more quickly identifying compounds for new treatments and vaccines, accelerating drug development, streamlining regulatory compliance, optimizing which patients ...

Preclinical drug evaluation, especially for cardiotoxicity, is a critical stage in the drug development process.